I supported the creation of a pathway for biosimilars, and for empowering FDA with the authority and resources to ensure that biosimilars are safely available here in the U.S. for the patients that need them the most.
Pitts discusses his support for biosimilar approval pathways to benefit patients.
Share
More from Joe Pitts
Today's hearing is especially timely as we learned startling news over the summer, confirming our worst fears, that the some of the most significant health insurers--UnitedHealth, Aetna, Humana--are opting out of Obamacare's health…
I for one in a portion of my life when I was a boy lived in a household where we didn't have access to health care.
The time of 10 o'clock having arrived, I will call this subcommittee meeting to order.
Trauma is the number-one cause of productive life years lost, greater than cancer or heart disease.
Other voices in this conversation
